Addressing Low HPV Vaccine Uptake in Nigeria: A Cross-Sectional Study of Maternal Knowledge, Perceptions, and Barriers in Akure South, Ondo State

Background: Cervical cancer remains a significant public health burden in Nigeria, with HPV vaccination being a critical primary prevention strategy. Despite the introduction of the national HPV immunization programme in 2023, uptake remains suboptimal. This study examined the factors influencing acceptance and uptake of HPV vaccines among mothers of teenage girls in Akure South Local Government Area, Ondo State, Nigeria.
Methods: We used a descriptive cross-sectional survey design. Two hundred and twenty (220) mothers of teenage girls (9–14 years, consistent with Nigeria's National HPV Immunization Programme and WHO recommendations) were selected across 12 political wards using a multistage sampling technique. We collected data using a structured, self-administered questionnaire and analyzed them using descriptive statistics and Pearson Product-Moment Correlation at a 0.05 significance level. Confidence intervals (95%) and effect sizes were reported where appropriate.

HPV vaccine, cervical cancer, awareness campaign, advocacy, vaccine uptake

1. Agba, A. M. (2022). Burden of cervical cancer in low- and middle-income countries: A Nigerian perspective. African Journal of Reproductive Health, 26(2), 12–20. [Google Scholar] [Crossref]

2. Akinola, O. I., et al. (2022). HPV vaccination uptake in Lagos: Barriers and opportunities. Nigerian Journal of Clinical Practice, 25(4), 456–463. [Google Scholar] [Crossref]

3. Alsous, M. M., et al. (2021). Knowledge and awareness of HPV vaccination. Journal of Infection and Public Health, 14(5), 661–667. [Google Scholar] [Crossref]

4. Asgedom, A., et al. (2025). Determinants of HPV vaccine uptake in East Africa. Vaccine, 43(1), 126–134. [Google Scholar] [Crossref]

5. Bhatla, N., & Singhal, S. (2020). Primary HPV screening for cervical cancer prevention. Best Practice & Research Clinical Obstetrics & Gynaecology, 65, 98–108. [Google Scholar] [Crossref]

6. Brown, C., et al. (2023). Acceptance and uptake of HPV vaccine among mothers of teenage girls in Anambra State, Nigeria. Nigerian Medical Journal, 64(2), 189–198. [Google Scholar] [Crossref]

7. Bruni, L., et al. (2021). Global estimates of human papillomavirus vaccination coverage by region and income level. Lancet Global Health, 9(7), e1015–e1025. [Google Scholar] [Crossref]

8. Ezechi, O. C. (2025). HPV vaccine uptake among teenage girls in Nigeria: A multi-center study. International Journal of Gynecology & Obstetrics, 168(2), 345–353. [Google Scholar] [Crossref]

9. Harun, A., et al. (2021). Health system barriers to HPV vaccination. International Journal of Public Health, 66, 1604063. [Google Scholar] [Crossref]

10. Kisaakye, E., et al. (2021). Community perceptions and HPV vaccination acceptance. Vaccine, 39(25), 3400–3407. [Google Scholar] [Crossref]

11. Nabirye, J., et al. (2020). Factors affecting HPV vaccine uptake in Sub-Saharan Africa. BMC Public Health, 20(1), 123. [Google Scholar] [Crossref]

12. Nigeria National Cancer Control Plan. (2022). National strategic plan for cancer control (2018–2022). Abuja: Federal Ministry of Health. [Google Scholar] [Crossref]

13. Nsofor, C. (2024). Vaccine adoption among teenage girls in Nigeria. Journal of Public Health in Africa, 15(1), 234–242. [Google Scholar] [Crossref]

14. Rosenstock, I. M., & Becker, M. H. (1994). The Health Belief Model and personal health behavior. Health Education Monographs, 2(4), 324–508. [Google Scholar] [Crossref]

15. Santhanes, D., et al. (2022). Determinants of HPV vaccine hesitancy. Human Vaccines & Immunotherapeutics, 18(5), 201–210. [Google Scholar] [Crossref]

16. Skinner, S. R., & Cooper, S. C. (2023). School-based vaccination programs and adolescent immunization coverage. Journal of Adolescent Health, 72(3), 345–352. [Google Scholar] [Crossref]

17. Sung, H., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates. CA: A Cancer Journal for Clinicians, 71(3), 209–249. [Google Scholar] [Crossref]

18. World Health Organization. (2022). Human papillomavirus (HPV) and cervical cancer. Geneva: WHO Press. [Google Scholar] [Crossref]

19. World Health Organization. (2023). WHO guideline for HPV vaccination strategies targeting cervical cancer elimination. Geneva: WHO. [Google Scholar] [Crossref]

20. World Health Organization. (2024). Cervical cancer prevention and control: Global strategy update. Geneva: WHO Press. [Google Scholar] [Crossref]

• Conflict of Law in the Safeguarding of Malaysian Intangible Cultural Heritage: A Way Forward
• Alternative Dispute Resolution in India: A Brief Overview Justice Delayed is Justice Denied. - William E. Gladstone
• The Role of Museums in Safeguarding Cultural Heritage Rights: Balancing Access and Repatriation
• An Evaluation of the Universal Declaration of Human Rights' Significance and Application in Nigeria
• The Role of International Law in Shaping National Immigration Policies.